Why insider trading matters?

Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.

- Peter Lynch
Organogenesis Holdings Inc. (ORGO)
Sector: Healthcare; Industry: Drug Manufacturers—Specialty & Generic

Organogenesis Holdings Inc., a regenerative medicine company, focuses on the development, manufacture, and commercialization of solutions for the advanced wound care, and surgical and sports medicine markets primarily in the United States. The company's pipeline products include TransCyte for the treatment of second- and third-degree burns; PuraForce, a bioengineered porcine collagen surgical matrix for use in soft tissue reinforcement applications; Novachor for the treatment of chronic and acute wounds; Gintuit for the treatment of mucogingival conditions in adults; and PuraPly XT and PuraPly MZ for the treatment of chronic and acute wounds, as well as for surgical treatment of open wounds. It serves hospitals, wound care centers, government facilities, ambulatory service centers, and physician offices. The company sells its products through direct sales representatives and independent agencies.

Trade Date Insider Title Buy/Sell #Shares Price Value Option
2020-12-02 MACKIE WAYNE D Director Buy 38,710 $5.26 $203,615 No
2020-11-17 MACKIE WAYNE D Director Buy 42,726 $3.25 $138,860 No
2019-09-13 MACKIE WAYNE D Director Buy 4,990 $6.13 $30,570 No
2019-09-11 MACKIE WAYNE D Director Buy 13,010 $5.30 $69,017 No
2019-09-04 MACKIE WAYNE D Director Buy 82,000 $4.47 $366,211 No

Insider Smart

ROYAL CARIBBEAN CRUISES (RCL) - Thompson Donald, Director of RCL feels safe and made a move. The only insiders bought RCL post crash.

Insider Smart

Planet Fitness, Inc (PLNT) - Our position in PLNT is also inspired by insider trading, if insiders are comfortable and confident buying around $50, it is an easy hold if you can pick it up at an even lower price. Our avg cost of the position is ~$40 and is now with 50% profit.